Aptevo (APVO) Form 4: Director awarded 7,200 RSUs vesting in one year
Rhea-AI Filing Summary
Aptevo Therapeutics director Harsanyi Zsolt was granted 7,200 restricted stock units (RSUs) on 08/06/2025. Each RSU converts one-for-one into common stock and is reported as a direct beneficial interest. The award carries a $0 price and vests in full on the first anniversary of the grant, meaning the holder would receive 7,200 common shares if vesting conditions are met. The reporting form lists a single reporting person and the grant was executed by an attorney-in-fact on behalf of the reporting person.
Positive
- Alignment of interests: Grant of 7,200 RSUs ties the director’s compensation to share performance through one-for-one conversion into common stock.
- Retention incentive: Full vesting after one year encourages continued service from the director.
Negative
- Potential dilution: The RSUs represent 7,200 potential shares upon vesting; the filing does not provide outstanding share count to assess materiality.
- Compensatory cost: The $0 price indicates a gratuitous grant that will be recorded as compensation expense for the issuer.
Insights
TL;DR: Routine director equity award that aligns interests with shareholders; materiality depends on company share count.
The grant of 7,200 RSUs to a director is a standard compensation and retention tool. The RSUs convert 1:1 to common stock and vest in full after one year, creating a clear time-based retention incentive. The award is recorded as a direct beneficial interest and shows a $0 price, consistent with compensatory grants. Assessing investor impact requires the issuer's outstanding share count, which is not provided in this filing.
TL;DR: Adds 7,200 potential shares on vesting; modest in isolation but requires context to judge dilution.
The Form 4 reports an acquisition of 7,200 RSUs exercisable one-for-one into common stock and vesting in full on the first anniversary. The transaction is recorded as a direct holding and carries no exercise price, indicating a grant rather than a purchase. From a market perspective, the item is informational; its impact on EPS or ownership concentration cannot be determined from this filing alone because total shares outstanding and other recent insider activity are not disclosed here.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 7,200 | $0.00 | -- |
Footnotes (1)
- Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. The RSUs vest in full on the first anniversary of the date of grant.
